Abstract:Aim: To design and synthesize a series of novel 7-hydroxy-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-4- carboxylate derivatives and evaluate their anti-HIV-1 activities. Methods: Holding the same triad of metal-chelating heteroatoms for the catalytic site of IN and introducing a new hydroxyl group into the adjacent position of the amide to form another three-heteroatoms group for metal chelation, a series of novel 7-hydroxy-1,3-dioxo-2,3-dihydro-1Hpyrrolo[ 3,4-c]pyridine-4-carboxylate derivatives were designed and synthesized through multi-step chemical reactions. All the synthesized compounds were evaluated for their inhibitory activities against HIV-1 replication. Results: Thirtyfive new compounds (5–13) have been designed, synthesized and bioassayed. Their structural features were determined by 1H-NMR spectra, and low- and high-resolution mass spectra. Most of the synthesized compounds showed moderate to potent activities against HIV-1. Among the analogs, compounds 7d, 7f, 7i-7j, 8d and 9c exhibited potent anti-HIV-1 activities (EC50<10 μM). In particular, 7d exhibited significant anti-HIV-1 activities with EC50 values of 1.65 μM. Conclusion: This study provides a new template for further development of potent anti-HIV-1 drugs, and the preliminary SAR among the newly synthesized analogs provided useful indications for guiding further rational design of potent anti-HIV-1 agents.

Synthesis and Biological Evaluation of Novel Anti-Hepatitis C Virus (HCV) Agents: 2-Hydroxylphenethyl Sulfanyl-Oxopyrimidines

Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives As Novel Hepatitis B Virus Capsid Assembly Modulators

Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives.

Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.

Discovery and Structure-Activity Relationships Study of Novel Thieno[2,3-B] Pyridine Analogues As Hepatitis C Virus Inhibitors

Synthesis and Anti-HBV Activity of Novel Dihydropyrimidine Analogs

A Novel Imidazolinone Derivative with 5‐arylidene and 2‐substituted Mercapto Group As Potent Anti‐Hepatitis C Virus Compound

Synthesis and Evaluation of Anti-HIV-1 Activities of Novel 7-Hydroxy-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-4-carboxylate Derivatives

Synthesis and Biological Evaluation of Triazolo-pyrimidine Derivatives As Novel Inhibitors of Hepatitis B Virus Surface Antigen (hbsag) Secretion

Synthesis and Evaluation of 3-Phenylisoxazoline Derivatives As Non-Nucleoside Hepatitis B Virus Inhibitors

A new series of HCV inhibitors based on a 2-(thieno[2,3b]pyridin-2-yl)-1,3,4-oxadiazole scaffold

Synthesis and Biological Evaluation of Novel Hydroxylphenethyl-S-DACOs As High Active Anti-HIV Agents

Synthesis and Biological Evaluation of Phenylpropanoid Derivatives

Synthesis and biological evaluation of novel pentacyclic triterpene α-cyclodextrin conjugates as HCV entry inhibitors

Design, Synthesis, Molecular Modeling Studies and Biological Evaluation of N'-Arylidene-6-(benzyloxy)-4-oxo-1,4-dihydroquinoline-3-carbohydrazide Derivatives as Novel Anti-HCV Agents

Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease

Synthesis and Anti-Hepatitis B Virus Activity of Novel Benzimidazole Derivatives

Synthesis and Anti-Hepatitis B Virus Evaluation of Novel Ethyl 6-Hydroxyquinoline-3-carboxylates in Vitro

Design and Synthesis of Novel Benzimidazole Derivatives As Inhibitors of Hepatitis B Virus

Design, Synthesis and Primary Biological Evaluation of the Novel 2-Pyridone Derivatives As Potent Non-Nucleoside HBV Inhibitors.

Design and Synthesis of (3-Phenylisoxazol-5-yl)methanimine Derivatives as Hepatitis B Virus Inhibitors